---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-241546"
form_type: "8-K"
ticker: "XENE"
cik: "0001582313"
company_name: "Xenon Pharmaceuticals Inc."
filed_at: "2025-10-16T23:59:59+00:00"
generated_at: "2026-05-17T03:33:01.878038+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Xenon appoints Tucker Kelly as CFO; grants 225K options, 30K RSUs

## Summary
- Tucker Kelly named CFO effective Oct 15, 2025; previously CFO at Deciphera (acquired by Ono for $2.4B).
- Annual base salary $540K; eligible for incentive up to 45% of base.
- One-time inducement grant: options for 225K shares at $41.90 (closing price Oct 15).
- One-time grant of 30,000 RSUs; both options and RSUs vest over 4 years.
- Interim CFO Ian Mortimer steps down but remains President & CEO as lead candidate azetukalner enters Phase 3.

## SEC filing metadata
- accession: 0001193125-25-241546
- form_type: 8-K
- ticker: XENE
- cik: 0001582313
- company_name: Xenon Pharmaceuticals Inc.
- filed_at: 2025-10-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582313/000119312525241546/0001193125-25-241546-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582313/000119312525241546/xene-20251015.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-241546
- JSON: https://secwatch.observer/filing/0001193125-25-241546.json
- Plain text: https://secwatch.observer/filing/0001193125-25-241546.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.